OpenAlex
PricingAboutJobs
Log inGet started
Work

Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial

HTML

Year: 2015
Type: article
Source: The Lancet Diabetes & Endocrinology
DOI: 10.1016/s2213-8587(14)70246-3
Authors: Dick de Zeeuw, Deborah A Anzalone, Valerie A Cain, Michael D Cressman, Hiddo J Lambers Heerspink, Bruce A Molitoris, John T Monyak, Hans-Henrik Parving, Giuseppe Remuzzi, James R Sowers, Donald G Vidt
Institutions: University Medical Center Groningen, University of Groningen, AstraZeneca (United States), Covance (United States), Indiana University Indianapolis, Indiana University School of Medicine, University of Copenhagen, Aarhus University, Rigshospitalet, Mario Negri Institute for Pharmacological Research, University of Missouri, Cleveland Clinic
Language: English

Topic: Chronic Kidney Disease and Diabetes
Subfield: Nephrology
Field: Medicine
Domain: Health Sciences
Keywords: atorvastatin, rosuvastatin, statins, diabetic nephropathy, proteinuria, urine protein-to-creatinine ratio, renal protection, type 1 diabetes, type 2 diabetes, ACE inhibitors, angiotensin receptor blockers, renin-angiotensin system blockade, lipid-lowering therapy, dose comparison
SDG: Good health and well-being

Open Access status: closed

Funder: AstraZeneca
OpenAlex ID: W2030853351
FWCI: 15.2
Cites: 32
Cited by: 187
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms